Therapy-related myeloid neoplasms following treatment for high-risk gestational trophoblastic neoplasia: a case series and retrospective analysis

Kaoru Niimi, Eiko Yamamoto, Kosuke Yoshida, Yuko Yasui, Hiroaki Kajiyama · 2026

Read Therapy-related myeloid neoplasms following treatment for high-risk gestational trophoblastic neoplasia: a case series and retrospective analysis by Kaoru Niimi, Eiko Yamamoto, Kosuke Yoshida, Yuko Yasui, Hiroaki Kajiyama (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13401578.txt.

Description

Kaoru Niimi and colleagues tracked a rare, severe late complication of chemotherapy for high-risk gestational trophoblastic neoplasia, a pregnancy-related tumor. Their 2026 series examines therapy-related myeloid neoplasms, including therapy-related leukemia, after multi-drug chemotherapy. These second blood cancers are uncommon but often fatal, and their frequency in this patient group had been unclear.

Reviewing 47 patients treated from 1990 to 2023, the team found four, or 8.5 percent, who developed therapy-related myeloid neoplasms three to five years after starting treatment. All four had received etoposide-containing regimens at cumulative doses of at least 6,000 milligrams per square meter, with KMT2A rearrangements or IDH mutations. Despite stem cell transplantation, all four died. The paper urges long-term blood monitoring after high-dose etoposide, even as curative chemotherapy remains essential.

Catalog record

CREATORKaoru Niimi, Eiko Yamamoto, Kosuke Yoshida, Yuko Yasui, Hiroaki Kajiyama
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13401578

Browse the full library · About the Tower of Babel